Alvaro Plaza Reyes is a Biotechnologist dedicated to cell therapy of retinal diseases since the beginning of his research career. He is currently working as a postdoctoral researcher at the Retinal Degeneration Group in CABIMER (Seville, Spain). Alvaro has wide research experience in the fields of human pluripotent stem cells and regenerative medicine. He has a Master in Biomedicine and a PhD in Medical Sciences, both from Karolinska Institutet. His research efforts are currently focused on the development of clinical-grade cell therapies (ATMP) for the treatment of retinal degenerative diseases. More specifically, one the projects in which he is currently involved focuses on the the laboratory production of the different cell types of the retina to build the cell layers of an organ-on-a-chip “artificial retina”.